AHR and cancer: Mechanistically, there is evidence that activation of the aryl hydrocarbon receptor (AhR) upon TCDD binding leads to BZLF1 gene expression and EBV reactivation in both B cells and salivary epithelial cells, which shows potential consequences in autoimmune diseases and cancer [199].